Efstratios Stratikos

29PUBLICATIONS
55CO-AUTHORS
Innate immunityBiomolecular modelling and designEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Engineering electromagnetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity In Vivo.

|Apr 13, 2026
Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 Inhibitors.

Robert P Law, Ian D Wall, Richard Lonsdale

|Oct 23, 2025
ERAP1 Allotypes 2 and 10 Differentially Regulate the Immunopeptidome of Melanocytes.

Martha Nikopaschou, Martina Samiotaki, Anna Kannavou

|May 12, 2025
Discovery of Novel Allosteric Inhibitor Hits for Insulin-Regulated Aminopeptidase Provides Insights on Enzymatic Mechanism.

Galateia Georgaki, Nikoletta-Maria Koutroumpa, Panagiotis Lagarias

|Dec 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design.

Ross P Hryczanek, Andrew S Hackett, Paul Rowland

|Aug 21, 2024
Stabilization of the open conformation οf insulin-regulated aminopeptidase by a novel substrate-selective small-molecule inhibitor.

Anastasia Mpakali, Galateia Georgaki, Alberto Buson

Pageof 5

Frequent Collaborators

6 joint publications

Athanasios Papakyriakou

5 joint publications

Anastasia Mpakali

4 joint publications

Christopher P Tinworth

3 joint publications

Richard Lonsdale